Type1 Screen

Type1Screen offers free type 1 diabetes risk screening to those aged over 2 years with ANY relative diagnosed with type 1 diabetes

[Type1 Screen @Type1Screen]

Optimistic results

[Diabetologia @DiabetologiaJnl]

In this real-world study, teplizumab treatment improved HbA1c, OGTT and CGM measurements within the first year of therapy. The preproinsulin targeting T cell receptors decreased after the treatment, which correlated with C-peptide AUC https://t.co/us7nRwqaYW 🔓#T1D

[Type1 Screen @Type1Screen]

The Finnish type 1 diabetes prediction & prevention (DIPP) study has found high intake of vitamin C and vitamin E to be associated with a decreased risk of islet autoimmunity (early marker for #type1diabetes)

[Diabetologia @DiabetologiaJnl]

High intake of vitamin C and E might reduce the risk of islet autoimmunity and type 1 diabetes in children genetically at risk for type 1 diabetes. @TampereUni @THLorg #vitaminA #vitaminB #vitaminC #vitaminD #vitaminE #Type1Diabetes #DIPPstudy https://t.co/fVxqnpiQTw 🔓

[Breakthrough T1D @BreakthroughT1D]

You know the phrase "knowledge is power"? That's what you gain when you or a family member gets screened for type 1 diabetes (T1D).

Visit the link below to learn more about screening and early detection!

https://t.co/hwk2vRg3ai

[Type1 Screen @Type1Screen]

#25ADC

[Type1 Screen @Type1Screen]

That’s a wrap for #ADC2025
Some wonderful and brave videos from Type1Screen and ENDIA Study families made our session a success @BetaCellCRE Thanks to all who attended

[Type1 Screen @Type1Screen]

@Prof_AJ_Jenkins 👏

[Type1 Screen @Type1Screen]

Genetic risk stratification could improve the efficiency of a future national screening program for #type1diabetes @DrKirstieBell

[Type1 Screen @Type1Screen]

Here with @DrKirstieBell at #adc2025 overviewing some findings from the national #type1diabetes screening pilot.

[Type1 Screen @Type1Screen]

Congratulations to Dr Sybil McAuley on her mid career researcher award at #adc2025 around #type1diabetes and therapeutic strategies

[Type1 Screen @Type1Screen]

We need a coordinated strategy in Australia to rethink regulatory approval and accelerate access in #type1diabetes states Dr Jennifer Snaith ⁦@GarvanInstitute⁩

[Type1 Screen @Type1Screen]

Look out for the upcoming TIRTLE2 Trial looking like it could bring about some promising results for those with #type1diabetes

[Type1 Screen @Type1Screen]

The #t1d tempest by Dr Jennifer Snaith and colleagues

[Type1 Screen @Type1Screen]

Amazing outcomes from #type1diabetes research by Prof Toby Coates and colleagues 👏

[Type1 Screen @Type1Screen]

Fantastic outcomes for this person with #type1diabetes who received gene modified allogenic islets hypo-immune platform (HIP) islets

[Type1 Screen @Type1Screen]

“The best way to get time in range for those with #type1diabetes is a pancreas transplant” says Prof Toby Coates. If only the immunosuppression wasn’t such a factor and we didn’t have to use someone else’s #pancreas 😢

[Type1 Screen @Type1Screen]

Preclinical #type1diabetes trial coming to Australia! So if families living with #T1D have been considering screening, now is the time. Go to https://t.co/AXQQ7H8Ckg for more information and registration

[Type1 Screen @Type1Screen]

The current early stage #type1diabetes landscape in Australia with thanks to funding from @BreakthroughT1D

[Type1 Screen @Type1Screen]

Look out for results of this study in around 2-3 years ⁦@ATIC_t1d⁩

[Type1 Screen @Type1Screen]

Immunopathogenesis of #type1diabetes outlined by Type1Screen’s Prof John Wentworth. How can we intervene in this process to stop #t1d progressing?

[Type1 Screen @Type1Screen]

Honoured that Type1Screen sits under the funded prevention pillar by @BreakthroughT1D